GeneDx Holdings ( $WGS): Holding Near $88 After Mid-September Rally and Guidance Revision (See the latest news for any ticker on Tickeron.) GeneDx Holdings (WGS) shares finished the past 30 days roughly flat near $88, after rallying above $100 in mid-September before pulling back on elevated volume. The company is a leader in whole exome and genome sequencing for pediatric and rare disease diagnosis, powered by its GeneDx Infinity genomic dataset. Management lowered full-year 2026 revenue guidance to $475–$490 million, citing lower average reimbursement rates and pressure in non-core business lines. $COIN $CLSK $RIOT $NTRA